Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 184 - 197Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Chin, RL, Sporer, KA, Cullison, B, et al. Clinical course of γ-hydroxybutyrate overdose. Ann Emerg Med 1998; 31: 716.CrossRefGoogle ScholarPubMed
Henderson, RS, Holmes, CM. Reversal of the anaesthetic action of sodium gamma-hydroxybutyrate. Anaesth Intens Care 1976; 4: 351.Google Scholar
Li, J, Stokes, SA, Wockener, A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998; 31: 729.Google Scholar
Mokhlesi, B, Garinella, PS, Joffe, A, et al. Street drug abuse leading to critical illness. Intens Care Med 2004; 30: 1526.Google Scholar
Mokhlesi, B, Leikin, JB, Murray, P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest 2003; 123: 897.Google Scholar
Viera, AJ, Yates, SW. Toxic ingestion of gamma-hydroxybutyric acid. South Med J 1999; 92: 404.Google Scholar
Bibliography
Anaya, D, Dellinger, E. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44: 705.Google Scholar
Bisno, AL, Stevens, DL. Streptococcal infections of skin and soft tissue. N Engl J Med 1996; 334: 240.CrossRefGoogle Scholar
Brown, RD, Davis, NL, Lepawski, M, et al. A multicentre review of the treatment of major truncal necrotising infections with and without hyperbaric oxygen therapy. Am J Surg 1994; 167: 483.Google Scholar
Dahl, PR, Perniciaro, C, Holmkvist, KA, et al. Fulminant group A streptococcal necrotizing fasciitis: clinical and pathologic findings in 7 patients. J Am Acad Dermatol 2002; 47: 489.Google Scholar
Davies, HD, McGeer, A, Schwartz, B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335: 547.Google Scholar
Devaney, B, Frawley, G, Frawley, J, et al. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intens Care 2015; 43: 685.Google Scholar
Eke, N. Fournier’s gangrene: a review of 1726 cases. Br J Surg 2000; 87: 718.CrossRefGoogle ScholarPubMed
Elliott, DC, Kufera, JA, Myers, RAM, et al. Necrotizing soft tissue infections: risk factors for mortality and strategies for management. Ann Surg 1996; 224: 672.Google Scholar
Giuliano, A, Lewis, F, Hadley, K, et al. Bacteriology of necrotizing fasciitis. Am J Surg 1977; 134: 52.Google Scholar
Hirschmann, JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Jarrett, P, Rademaker, M. Duffill, M. The clinical spectrum of necrotising fasciitis. Aust NZ J Med 1997; 27: 29.Google Scholar
Kaul, R, McGeer, A, Low, DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiological analysis of seventy-seven cases. Am J Med 1997; 103: 18.Google Scholar
Lille, ST, Sato, TT, Engray, LH, et al. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg 1996; 182; 7.Google Scholar
Phan, HH, Cocanour, CS. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med 2010; 38 (suppl.): S460.Google Scholar
Riegels-Nielsen, P, Hesselfeldt-Nielsen, J, Bang-Jensen, E, et al. Fournier’s gangrene. J Urol 1984; 132: 918.Google Scholar
Stevens, DL, Bryant, AE. Necrotizing soft-tissue infections. N Engl J Med 2017; 377: 2253.CrossRefGoogle ScholarPubMed
Unsworth, IP, Sharp, PA. Gas gangrene: an 11-year review of 73 cases managed with hyperbaric oxygen. Med J Aust 1984; 140: 256.Google Scholar
Urbina, T, Madsen, MB, de Prost, N. Understanding necrotizing soft tissue infections in the intensive care unit. Intens Care Med 2020; 46: 1739.Google Scholar
Ustin, JS, Malangoni, MA. Necrotizing soft-tissue infections. Crit Care Med 2011; 39: 2156.Google Scholar
Bibliography
Giuliano, A, Lewis, F, Hadley, K, et al. Bacteriology of necrotizing fasciitis. Am J Surg 1977; 134: 52.Google Scholar
Unsworth, IP, Sharp, PA. Gas gangrene: an 11-year review of 73 cases managed with hyperbaric oxygen. Med J Aust 1984; 140: 256.Google Scholar
Bibliography
Heyland, D, Cook, DJ, Winder, B, et al. Enteral nutrition in the critically ill patient: a prospective study. Crit Care Med 1995; 23: 1055.Google Scholar
Lewis, K, Alqahtani, Z, Mcintyre, L, et al. The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Crit Care 2016; 20: 259.Google Scholar
Montejo, JC, Minambres, E, Bordeje, L, et al. Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intens Care Med 2010; 36: 1386.Google Scholar
Bibliography
Abraham, E, ed. Acid suppression in a critical care environment. Crit Care Med 2002; 30: no.6, suppl.Google Scholar
Barie, PS, Fischer, E, Eachempati, SR. Acute acalculous cholecystitis. Curr Opin Crit Care 1999; 5: 144.Google Scholar
Berger, HG, Matsuno, S, Cameron, JL, eds. Diseases of the Pancreas. Berlin: Springer. 2008.Google Scholar
Blaser, MJ, Smith, PD, Ravdin, JL, et al., eds. Infections of the Gastrointestinal Tract. 2nd edition. New York: Raven Press. 2002.Google Scholar
Doe, WF. The immunology of the gut. In: Peters, PJ, Rosen, FS, Walport, M, eds. Clinical Aspects of Immunology. 4th edition. Oxford: Blackwell. 1993; p 2079.Google Scholar
Dooley, J, Lok, ASF, Garcia-Tsao, G, et al., eds. Sherlock’s Diseases of the Liver and Biliary System. 13th edition. Hoboken: Wiley. 2018.Google Scholar
Fehily, SR, Basnayake, C, Wright, EK, et al. The gut microbiota and gut disease. Intern Med J 2021; 51: 1594.Google Scholar
Feldman, M, Friedman, L, Brandt, L. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th edition. Philadelphia: Elsevier. 2020.Google Scholar
Go, VLW, et al., eds. The Pancreas: Biology, Pathobiology and Diseases. New York: Raven Press. 1993.Google Scholar
Johnston, DE, Kaplan, MM. Pathogenesis and treatment of gallstones. N Engl J Med 1993; 328: 412.Google Scholar
Mutlu, GM, Mutlu, EA, Factor, P. GI complications in patients receiving mechanical ventilation. Chest 2001; 119: 1222.Google Scholar
Powell, LW, Piper, DW, eds. Fundamentals of Gastroenterology. 6th edition. Sydney: McGraw-Hill. 1995.Google Scholar
Shearman, DJC, Finlayson, NDC. Diseases of the Gastrointestinal Tract and Liver. 2nd edition. Edinburgh: Churchill Livingstone. 1989.Google Scholar
Various. Gastroenterology. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Charrow, J, Esplin, JA, Gribble, TJ, et al. Gaucher disease: recommendations on diagnosis, evaluation and monitoring. Arch Intern Med 1998; 158: 1754.Google Scholar
Jmoudiak, M, Futerman, AH. Gaucher disease: pathological mechanisms and modern management. Br J Haematol 2005; 129: 178.Google Scholar
Meikle, PJ, Hopwood, JJ, Clague, AE, et al. Prevalence of lysosomal storage disorders. JAMA 1999; 281: 249.Google Scholar
Szer, J, Peters, H. Gaucher disease: a multi-organ disorder with a heterogeneous phenotype. Intern Med J 2020; 50 (suppl 4): 7.Google Scholar
Bibliography
Breman, JG, Henderson, DA. Diagnosis and management of smallpox. N Engl J Med 2002; 346: 1300.Google Scholar
Rotz, LD, Khan, AS, Lillibridge, SR, et al. Public health assessment of potential bioterrorism agents. Emerg Infect Dis 2002; 8: 225.Google Scholar
Whitby, M, Ruff, TA, Street, AC, et al. Biological agents as weapons 2: anthrax and plague. Med J Aust 2002; 176: 605.Google Scholar
Bibliography
Deane, A, Chapman, MJ, Fraser, RJL, et al. Bench-to-bedside: the gut as an endocrine organ in the critically ill. Crit Care 2010; 14: 228.CrossRefGoogle Scholar
Bibliography
Abraham, PA, Keane, WF. Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 1984; 4: 1.Google Scholar
Balow, JE, Austin, HA, Tsokos, GC, et al. Lupus nephritis. Ann Intern Med 1987; 106: 79.Google Scholar
Bonegio, RGB, Salant, DS. Glomerular diseases. In: Scientific American Medicine. Nephrology. Hamilton: Dekker Medicine. 2020.Google Scholar
Llach, F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of the nephrotic syndrome. Kidney Int 1985; 28: 429.Google Scholar
Morgan, DB, Dillon, S, Payne, RB. The assessment of glomerular function: creatinine clearance or plasma creatinine? Postgrad Med J 1978; 54: 302.Google Scholar
Muirhead, N. Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int 1999; 70 (suppl.): S47.CrossRefGoogle ScholarPubMed
Nolin, L, Courteau, M. Management of IgA nephropathy: evidence based recommendations. Kidney Int 1999; 70 (suppl.): S56.Google Scholar
Ronco, PM, Flahault, A. Drug-induced end-stage renal disease. N Engl J Med 1994; 331: 1711.Google Scholar
Turner, NN, Lamiere, N, Goldsmith, DJ, et al., eds. Oxford Textbook of Clinical Nephrology. 4th edition. Oxford: Oxford University Press. 2018.Google Scholar
Bibliography
Bibliography
Beutler, E. The genetics of glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990; 27: 137.Google Scholar
Bibliography
Ait-Outfella, H, Maury, E, Lehoux, S, et al. The endothelium: physiological functions and role of microcirculatory failure during sepsis. Intens Care Med 2010; 36: 1286.Google Scholar
Iba, T, Levy, JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost 2019; 17: 283.Google Scholar
Reitsma, S, Slaaf, DW, Vink, H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345.Google Scholar
Weinbaum, S, Tarbell, JM, Damiano, ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121.Google Scholar
Bibliography
Pears, JS, Jung, RT, Hopwood, D, et al. Glycogen storage disease diagnosed in adults. Quart J Med 1992; 82: 207.Google Scholar
Talente, GM, Coleman, RA, Alter, C, et al. Glycogen storage disease in adults. Ann Intern Med 1994; 120: 218.Google Scholar
Bibliography
Green, RJ, Ruoss, SJ, Kraft, SA, et al. Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest 1996; 110: 1305.CrossRefGoogle ScholarPubMed
Joachimescu, OC, Sieber, S, Koch, A. Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 2004; 24: 162.Google Scholar
Kefalides, NA. The Goodpasture antigen and basement membranes: the search must go on. Lab Invest 1987; 56: 1.Google Scholar
Kelly, PT, Haponik, EF. Goodpasture syndrome: molecular and clinical advances. Medicine 1994; 73: 171.Google Scholar
Leatherman, JW, Davies, SF, Hoidal, JR. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine 1984; 63: 343.Google Scholar
Pacheo, A, Casanova, C, Fogue, L, et al. Long-term clinical follow-up of adult idiopathic pulmonary hemosiderosis and celiac disease. Chest 1991; 99: 1525.Google Scholar
Turner, N, Mason, PJ, Brown, R, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the α3 chain of type IV collagen. J Clin Invest 1992; 89: 592.Google Scholar
Young, KR. Diagnostic pitfalls in alveolar hemorrhage syndromes. Pulmonary Perspectives 2000; 17: 11.Google Scholar
Bibliography
Boss, GR, Seegmiller, JE. Hyperuricemia and gout: classification, complications and management. N Engl J Med 1979; 300: 1459.Google Scholar
Dieppe, PA, Huskisson, EC, Crocker, P, et al. Apatite deposition disease: a new arthropathy. Lancet 1976; 1: 266.Google Scholar
Edwards, Nl. Crystal-induced joint disease. In: Scientific American Medicine. Rheumatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Fam, AG. Treating acute gouty arthritis with selective COX 2 inhibitors. BMJ 2002; 325: 980.Google Scholar
Galassi, FM, Borghi, C. A brief history of uric acid from gout to cardiovascular risk factor. Eur J Intern Med 2015; 26: 373.Google Scholar
Gupta, MN, Sturrock, RD, Field, M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis 2003; 62: 327.Google Scholar
Hadler, NM, Franck, WA, Bress, NM, et al. Acute polyarticular gout. Am J Med 1974; 56: 715.Google Scholar
Hui, M, Carr, A, Cameron, S, et al. The British Society for Rheumatology guidelines for the management of gout. Rheumatology 2017; 56: e1.Google Scholar
Mikula, TR, Sang, KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006; 18: 199.Google Scholar
Pascual, E. Gout update: from lab to the clinic and back. Curr Opin Rheumatol 2000; 12: 213.Google Scholar
Stamp, LK, O’Donnell, JL, Chapman, PT. Emerging therapies in the long-term management of hyperuricaemia and gout. Intern Med J 2007; 37: 258.Google Scholar
Ting, K, Graf, SW, Whittle, SL. Update on the diagnosis and management of gout. Med J Aust 2015; 203: 86.Google Scholar
Yu, KH, Luo, SF, Liou, LB, et al. Concomitant septic and gouty arthritis: an analysis of 30 cases. Rheumatology 2003; 42: 1062.Google Scholar
Bibliography
Ashbury, AK, Cornblath, DR. Assessment of current diagnostic criteria for Guillain–Barre syndrome. Ann Neurol 1990; 27 (suppl.): S21.Google Scholar
Bromberg, MB, Feldman, EL, Albers, JW. Chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1992; 42: 1157.Google Scholar
Dalakas, MC, Engel, WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9 (suppl.): 134.Google Scholar
Feasby, TE, Hughes, RA. Campylobacter jejuni, antiganglioside antibodies, and Guillain–Barré syndrome. Neurology 1998; 51: 340.Google Scholar
Fisher, M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956; 255: 57.Google Scholar
Fuller, GN, Jacobs, JM, Guiloff, RJ. Nature and incidence of peripheral neuropathy syndromes in HIV infection. J Neurol Neurosurg Psychiatry 1993; 56: 372.Google Scholar
Haber, P, DeStafano, F, Angulo, FJ, et al. Guillain–Barré syndrome following influenza vaccination. JAMA 2004; 292: 2478.Google Scholar
Hughes, RAC. Ineffectiveness of high-dose intravenous methylprednisolone in Guillain–Barré syndrome. Lancet 1991; 338: 1142.Google Scholar
Hughes, RA, van der Meche, FG. Corticosteroids for treating Guillain–Barré syndrome. Cochrane Database Systematic Review 2000; 2: CD001446.Google Scholar
Lasky, T, Terracciano, GJ, Magder, L, et al. The Guillain–Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998; 339: 1797.Google Scholar
Misawa, S, Kuwahara, S, Sato, Y, et al. Safety and efficacy of eculizumab in Guillain–Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol 2018; 17: 519.Google Scholar
Moore, P, Owen, J. Guillain–Barré syndrome: incidence, management and outcome of major complications. Crit Care Med 1981; 9: 549.Google Scholar
Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome. Lancet 1997; 349: 225.Google Scholar
Rees, JH, Soudain, SE, Gregson, NA, et al. Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med 1995; 333: 1374.Google Scholar
Ropper, AH. Campylobacter diarrhea and Guillain–Barré syndrome. Arch Neurol 1988; 45: 655.CrossRefGoogle ScholarPubMed
Ropper, AH, Victor, M. Influenza vaccination and the Guillain–Barré syndrome. N Engl J Med 1998; 339: 1845.Google Scholar
Shahrizaila, N, Yuki, N. Bickerstaff brainstem encephalitis and the Fisher syndrome: anti-CQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 2013; 84: 576.Google Scholar
van der Meche, FGA, Schmitz, PIM. The Dutch Guillain–Barré Study Group: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain–Barré syndrome. N Engl J Med 1992; 326: 1123.Google Scholar
van Doorn, PA, Ruts, L, Jacobs, BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol 2008; 7: 939.Google Scholar
Winer, JB. Bickerstaff’s encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2001; 71: 433.Google Scholar